Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Interim Management Statement

9 Feb 2017 07:00

RNS Number : 3784W
Dairy Crest Group PLC
09 February 2017
 

 

9 February 2017

 

Dairy Crest Group plc ("Dairy Crest")

 

Interim Management Statement

 

Dairy Crest is today issuing its Interim Management Statement for the nine months ended 31 December 2016.

 

Outlook

 

The outlook for the full year remains in line with our expectations.

 

Branded performance

 

Our key brands have continued to perform well. Clover, Frylight and Country Life have all grown volumes in the first nine months of the year and have taken significant share in their respective markets. As predicted, Cathedral City performance improved in the third quarter.

 

Overall, in the first nine months of the year the combined volumes of Cathedral City, Country Life, Clover and Frylight are in line with the same period last year.

 

Innovation and brand building continues to be at the heart of what we do. Clover and Frylight have both seen new packaging launches during the quarter and Frylight has been supported by a new TV advertising campaign over the last six weeks. In January 2017, Clover won the spreads category "Product of the Year 2017" award in the world's largest consumer survey award for product innovation. This is a testimony to the work we undertook to remove artificial ingredients from Clover. Furthermore, in October 2016 Frylight won the Institute of Grocery and Distribution Health and Wellness award. We will continue to invest in innovation and marketing across our key brands through 2017.

 

Functional Ingredients

 

Production of demineralised whey powder and galacto-oligosaccharide ("GOS"), both ingredients for the growing global infant formula market, continues to develop well at our factory in Davidstow. There have been significant improvements in the percentage level of demineralised whey hitting the important infant formula grade. We remain confident that this will continue to rise and that we will hit our target of over 80% by 31 March 2017.

 

On 21 December 2016, Dairy Crest announced that it had entered into a research partnership with Danisco Animal Nutrition, part of DuPont, to further explore the potential uses of GOS in poultry and swine. If successful, this work would help to broaden the potential market for GOS beyond infant formula.

 

Balance sheet

 

We have seen further milk cost inflation since the half year and have now announced increases in the price paid to farmers of 8.28 pence per litre since June 2016. This represents an increase of 38%. Furthermore, market prices for cream have remained high after more than doubling in the first half of the year. The cream price determines the input costs for our butter business. These movements inevitably result in a short-term working capital outflow and, as a result, we now expect year end net debt to be somewhat higher than 31 March 2016.

 

New auditor appointment

 

The Board has approved the appointment of Deloitte as external auditor for the year commencing 1 April 2017. This appointment will be subject to shareholder approval at the 2017 Annual General Meeting. The Group's current auditor, Ernst & Young, is retiring by rotation and will carry out the audit for the year ending 31 March 2017. The Board would like to thank Ernst & Young for their contribution to the business over many years.

 

 

 

Mark Allen, Chief Executive of Dairy Crest, commented:

 

"The outlook for the full year remains in line with our expectations.

 

The business has continued to make progress during the quarter. Our brands have performed well supported by successful innovation and brand investment. I'm particularly pleased to see the improvement in Cathedral City's performance.

 

At the new Davidstow functional ingredients facility we are seeing significant improvement in the percentage level of demineralised whey meeting infant formula grade. This is important in maximising future opportunities in this market.

 

The announcement of the partnership with Danisco Animal Nutrition marks a further significant step in the development of GOS beyond infant formula. This has exciting potential opportunities for the future."

 

 

Dairy Crest will issue its Preliminary Results for the year ending 31 March 2017 on 18 May 2017.

 

 

 

For further information, please contact:

Dairy Crest

Alistair Smith

01372 472236

Dairy Crest

Tom Atherton

01372 472264

Brunswick

Mike Smith

0207 404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQVLFBDLFBBBX
Date   Source Headline
26th Jun 20095:20 pmRNSDirector/PDMR Shareholding
19th Jun 20097:00 amRNSFurther Measures to Reduce Pension Fund Risk
9th Jun 20098:56 amRNSDirector/PDMR Shareholding
28th May 20094:34 pmRNSDirector/PDMR Shareholding
19th May 20097:00 amRNSFinal Results
12th May 20096:25 pmRNSHolding(s) in Company
8th May 20093:46 pmRNSHolding(s) in Company
28th Apr 20095:19 pmRNSHolding(s) in Company
16th Apr 20099:03 amRNSHolding(s) in Company
15th Apr 200912:48 pmRNSDirectorate Change
2nd Apr 20092:54 pmRNSAdditional Listing (Replacement)
1st Apr 200910:41 amRNSTotal Voting Rights
31st Mar 20099:21 amRNSAdditional Listing
27th Mar 20097:00 amRNSTrading Statement
27th Feb 20099:47 amRNSHolding(s) in Company
10th Feb 200911:09 amRNSDirector/PDMR Shareholding-Replacement
10th Feb 200910:18 amRNSDirector/PDMR Shareholding
3rd Feb 20097:00 amRNSInterim Management Statement
16th Jan 20095:32 pmRNSHolding(s) in Company
22nd Dec 200812:36 pmRNSHolding(s) in Company (Replacement)
22nd Dec 200811:27 amRNSHolding(s) in Company
19th Dec 20087:00 amRNSCC PROVISIONALLY CLEARS STILTON MERGER
17th Dec 20087:00 amRNSPension Scheme and Net Debt Exposure
11th Dec 20087:23 amRNSResignation of Executive Managing Director
19th Nov 20088:51 amRNSDirector/PDMR Shareholding
10th Nov 20087:00 amRNSInterim Results
30th Sep 20084:57 pmRNSTotal Voting Rights
30th Sep 20087:00 amRNSTrading Statement
8th Sep 20085:24 pmRNSDirector/PDMR Shareholding
1st Sep 20084:34 pmRNSTotal Voting Rights
15th Aug 200812:47 pmRNSDoc re. AGM Resolutions
14th Aug 20083:00 pmRNSMerger Update
31st Jul 20086:23 pmRNSTotal Voting Rights
30th Jul 200811:30 amRNSDisposal of Stilton and speci
17th Jul 20082:42 pmRNSResult of AGM
17th Jul 20087:00 amRNSInterim Management Statement
2nd Jul 20081:22 pmRNSDirector/PDMR Shareholding
2nd Jul 20081:19 pmRNSAnnual Information Update
2nd Jul 20081:15 pmRNSTotal Voting Rights
2nd Jul 20089:37 amRNSDirector/PDMR Shareholding
30th Jun 20081:30 pmRNSSt Hubert Site Visit
26th Jun 200811:52 amRNSDirector/PDMR Shareholding
30th May 20084:43 pmRNSCORRECTION: Directors' Share
30th May 200812:47 pmRNSDirectors' Share Purchases
20th May 20087:00 amRNSPreliminary Results
30th Apr 20085:31 pmRNSTotal Voting Rights
2nd Apr 200812:09 pmRNSTotal Voting Rights
28th Mar 200811:16 amRNSMerger Update
28th Mar 20087:01 amRNSPre-close Trading Update
26th Mar 20086:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.